What is the relationship between Parkinson's disease and fungal skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Link Between Parkinson's Disease and Fungal Skin Infections

Patients with Parkinson's disease have an increased susceptibility to fungal skin infections, particularly seborrheic dermatitis, which may be related to both underlying disease mechanisms and medication side effects. 1, 2

Dermatological Manifestations in Parkinson's Disease

Common Fungal Infections in Parkinson's Disease

  • Seborrheic dermatitis is the most common fungal-related skin condition in Parkinson's disease patients, with significantly higher prevalence than in the general population 1, 2
  • Malassezia species (yeast) are implicated in seborrheic dermatitis and have been identified in central nervous system samples from Parkinson's disease patients 3
  • Candida species infections may occur, particularly in patients with advanced disease who are bedridden or have reduced mobility 4, 3

Pathophysiological Mechanisms

  • Altered sebum production and composition in Parkinson's disease creates an environment favorable for fungal colonization 2, 5
  • Autonomic dysfunction leads to hyperhidrosis (excessive sweating) in some patients, creating moist conditions that promote fungal growth 1, 5
  • Reduced immune function associated with Parkinson's disease may contribute to increased susceptibility to opportunistic fungal infections 2, 3

Medication-Related Factors

Antiparkinsonian Medications and Fungal Infections

  • Dopaminergic medications can alter sweat gland function and sebum production, potentially creating conditions favorable for fungal growth 1
  • Long-term use of levodopa and other medications may affect skin barrier function 1, 5
  • Immunomodulatory effects of certain Parkinson's medications may influence susceptibility to fungal infections 2

Management Considerations

  • Aggressive evaluation of skin lesions through culture aspiration, biopsy, or surgical excision is recommended for accurate diagnosis of fungal infections 6, 4
  • First-line therapy for cutaneous candidiasis includes topical antifungals, with systemic therapy reserved for disseminated infection 6, 4
  • For seborrheic dermatitis, antifungal shampoos containing ketoconazole or selenium sulfide are effective 2, 7

Emerging Research

Microbial Involvement in Parkinson's Disease

  • Recent research has identified fungal species including Botrytis, Candida, Fusarium, and Malassezia in brain tissue samples from Parkinson's disease patients 3
  • These findings suggest a potential role for fungal infections in the neuroinflammatory processes observed in Parkinson's disease 3
  • The gut-brain axis may be involved, with dysbiosis potentially contributing to both neurological symptoms and altered immune responses that affect skin health 2, 3

Clinical Implications

Diagnostic Approach

  • Regular dermatological assessment should be part of routine care for Parkinson's disease patients 1, 5
  • Skin lesions should be evaluated promptly, as they may represent fungal infections requiring specific treatment 6, 4
  • Microscopic examination with special fungal stains (periodic acid-Schiff, Grocott's methenamine silver) is recommended for accurate diagnosis 6

Treatment Considerations

  • Treatment should address both the fungal infection and underlying factors that predispose to infection 4, 7
  • For bedridden patients with Parkinson's disease, preventive measures such as daily chlorhexidine bathing may reduce the risk of fungal infections 4
  • Systemic antifungal therapy is warranted for disseminated infections, with echinocandins as first-line agents for systemic candidiasis 6, 4

Common Pitfalls and Caveats

  • Fungal skin infections in Parkinson's patients may be misdiagnosed as medication side effects or other dermatological conditions 2, 5
  • Premature discontinuation of antifungal therapy can lead to relapse, particularly in immunocompromised patients 4
  • Fluconazole-resistant yeast species (C. krusei and C. glabrata) are increasingly common due to widespread use of azole prophylaxis and should be considered in treatment-resistant cases 6, 4

References

Research

Parkinson's disease and skin.

Parkinsonism & related disorders, 2021

Research

Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue.

International journal of biological sciences, 2020

Guideline

Diagnosis and Management of Cutaneous Candidiasis in Bedridden Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Parkinson's disease and the skin.

Practical neurology, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Common viral and fungal skin infections.

Ostomy/wound management, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.